BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15763307)

  • 1. Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study.
    Martin J; Fitzpatrick K; Horan G; McCloy R; Buckney S; O'Neill L; Faul C
    Radiother Oncol; 2005 Mar; 74(3):267-74. PubMed ID: 15763307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.
    Gunnlaugsson A; Kjellén E; Nilsson P; Bendahl PO; Willner J; Johnsson A
    Acta Oncol; 2007; 46(7):937-44. PubMed ID: 17851844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer.
    Park W; Huh SJ; Lee JE; Han Y; Shin E; Ahn YC; Lim DH
    Gynecol Oncol; 2005 Dec; 99(3):645-51. PubMed ID: 16154184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.
    Tho LM; Glegg M; Paterson J; Yap C; MacLeod A; McCabe M; McDonald AC
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):505-13. PubMed ID: 16879928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer.
    Beriwal S; Jain SK; Heron DE; de Andrade RS; Lin CJ; Kim H
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):485-9. PubMed ID: 17084548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute diarrhea during pelvic irradiation: is small-bowel volume effect different in gynecologic patients with prior abdomen operation or not?
    Huang EY; Hsu HC; Yang KD; Lin H; Wang FS; Sun LM; Tsai CC; Changchien CC; Wang CJ
    Gynecol Oncol; 2005 Apr; 97(1):118-25. PubMed ID: 15790447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study.
    Rochet N; Sterzing F; Jensen AD; Dinkel J; Herfarth KK; Schubert K; Eichbaum MH; Schneeweiss A; Sohn C; Debus J; Harms W
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1382-9. PubMed ID: 19628341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study.
    Chopra S; Dora T; Chinnachamy AN; Thomas B; Kannan S; Engineer R; Mahantshetty U; Phurailatpam R; Paul SN; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):630-5. PubMed ID: 24521678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer.
    Robertson JM; Lockman D; Yan D; Wallace M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):413-8. PubMed ID: 17904305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a belly board device to reduce the small bowel volume within pelvic radiation fields in women with postoperatively treated cervical carcinoma.
    Ghosh K; Padilla LA; Murray KP; Downs LS; Carson LF; Dusenbery KE
    Gynecol Oncol; 2001 Nov; 83(2):271-5. PubMed ID: 11606083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of small bowel toxicity in postoperative pelvic irradiation for gynaecological malignancies.
    Huscher A; Bignardi M; Magri E; Vitali E; Pasinetti N; Costa L; Frata P; Magrini SM
    Anticancer Res; 2009 Nov; 29(11):4821-6. PubMed ID: 20032441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?
    Adli M; Mayr NA; Kaiser HS; Skwarchuk MW; Meeks SL; Mardirossian G; Paulino AC; Montebello JF; Gaston RC; Sorosky JI; Buatti JM
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):230-8. PubMed ID: 12909238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.